| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CEFAZOLIN SODIUM | 203661 | 001 | ANDA | CEFAZOLIN SODIUM | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL | No | No | 2015/12/28 | 2015/12/28 | QILU | Prescription |
| CEFAZOLIN SODIUM | 203661 | 002 | ANDA | CEFAZOLIN SODIUM | INJECTABLE;INJECTION | EQ 2GM BASE/VIAL | No | No | 2015/12/28 | 2022/03/11 | QILU | Prescription |
| CEFAZOLIN SODIUM | 203661 | 003 | ANDA | CEFAZOLIN SODIUM | INJECTABLE;INJECTION | EQ 3GM BASE/VIAL | No | No | 2015/12/28 | 2024/01/24 | QILU | Prescription |
| CEFAZOLIN SODIUM | 201654 | 001 | ANDA | CEFAZOLIN SODIUM | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL | No | No | 2016/02/03 | 2016/02/03 | HOSPIRA | Discontinued |
| CEFAZOLIN SODIUM | 209217 | 001 | ANDA | CEFAZOLIN SODIUM | INJECTABLE;INJECTION | EQ 10GM BASE/VIAL | No | Yes | 2018/10/17 | 2018/10/17 | QILU | Prescription |
| CEFAZOLIN SODIUM | 216109 | 001 | NDA | CEFAZOLIN SODIUM | POWDER;INTRAVENOUS | EQ 2GM BASE/VIAL | Yes | Yes | 2022/10/07 | 2022/10/07 | HIKMA | Prescription |
| CEFAZOLIN SODIUM | 216109 | 002 | NDA | CEFAZOLIN SODIUM | POWDER;INTRAVENOUS | EQ 3GM BASE/VIAL | Yes | Yes | 2022/10/07 | 2022/10/07 | HIKMA | Prescription |
| CEFAZOLIN SODIUM | 211413 | 001 | NDA | CEFAZOLIN SODIUM | POWDER;INTRAVENOUS | EQ 2GM BASE/VIAL | Yes | Yes | 2023/05/08 | 2023/05/08 | HQ SPCLT PHARMA | Prescription |